Modalis Therapeutics Reports Second Quarter 2020 Financial Results and Operational Highlights
Successful Initial Public Offering completed and continued advancement of a broad portfolio of novel epigenetic gene modulation programs TOKYO &...
Successful Initial Public Offering completed and continued advancement of a broad portfolio of novel epigenetic gene modulation programs TOKYO &...
Core operating performance continues an upward trend, revenue up 10.5% to RMB388 million while core net profit up 14.4% to...
Co-developed solution bridges the gap between devops and security operations teams HONG KONG, CHINA - Media OutReach - August...
HONG KONG, CHINA - Media OutReach - 28 August 2020 - Huami Corp. and Huami-USA (NYSE: HMI), a healthcare services company whose...
Proposed interim dividend of HK11 cents per share Contracted sales and cash collection for first seven months both exceeded RMB...
MANILA, PHILIPPINES - Media OutReach - 28 August 2020 - With a young population learning to be entrepreneurs (average of 24.4 years old...
SINGAPORE - Media OutReach - 28 August 2020 - Gram started in 2014 helping B2B companies with their proprietary G.R.A.M. Full-stack Video Framework,...
Michael Terence Publishing is excited to announce the release of "Beware the Snap of a Twig" – a French Resistance...
Michael Terence Publishing is excited to announce the release of "A Very Romantic Story About No Romance: The Love Story...
SMi reports: A key topic of discussion at the Unmanned Maritime Systems Technology Conference in London, this November, will be...
The Most Advanced Path Tracing GPU for Photo-realistic Graphics SEOUL, South Korea--(BUSINESS WIRE)--SiliconArts today released RC-MC, its next generation RayCore...
Revenue increased 26.9% to US$198 million; EBITDA up 27.3% to US$269 million PATMI achieved outsized growth of 75.1% to US$133...
HubBroker announces launch of an Automatic Invoice Reminder App that can be integrated into major accounting & ERP systems including...
Revenue and Core Net Profit Increase 10.5% and 14.4% to RMB388 million and RMB270 million Respectively Despite COVID-19 Core...
Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials...